Research ExplorerPublications[Prognostic markers for prostate cancer]

[Prognostic markers for prostate cancer]

Standard

[Prognostic markers for prostate cancer]. / Graefen, M; Hammerer, P; Noldus, J; Haese, Alexander; Pichelmeier, U; Erbersdobler, A; Henke, H; Conrad, S; Fernandez, S; Huland, H.

In: UROLOGE, Vol. 39, No. 1, 1, 2000, p. 14-21.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Graefen, M, Hammerer, P, Noldus, J, Haese, A, Pichelmeier, U, Erbersdobler, A, Henke, H, Conrad, S, Fernandez, S & Huland, H 2000, '[Prognostic markers for prostate cancer]', UROLOGE, vol. 39, no. 1, 1, pp. 14-21. <http://www.ncbi.nlm.nih.gov/pubmed/10663191?dopt=Citation>

APA

Graefen, M., Hammerer, P., Noldus, J., Haese, A., Pichelmeier, U., Erbersdobler, A., Henke, H., Conrad, S., Fernandez, S., & Huland, H. (2000). [Prognostic markers for prostate cancer]. UROLOGE, 39(1), 14-21. [1]. http://www.ncbi.nlm.nih.gov/pubmed/10663191?dopt=Citation

Vancouver

Graefen M, Hammerer P, Noldus J, Haese A, Pichelmeier U, Erbersdobler A et al. [Prognostic markers for prostate cancer]. UROLOGE. 2000;39(1):14-21. 1.

Bibtex

@article{deaaaeec541144159b811031e41b5cab,
title = "[Prognostic markers for prostate cancer]",
abstract = "Careful consideration of therapy for prostate cancer needs an accurate analysis of prognostic markers to estimate success and benefit for the patient. Prognosis of prostate cancer is determined by the proportion of high grade cancer, many usually utilized prognostic characteristics were rejected by multivariate analysis as no independent prognostic information was delivered. For planning therapy it is crucial to estimate the proportion of high grade cancer as exact as possible. A standardized biopsy technique combined with a quantified analysis of the biopsy cores is most helpful to achieve this goal. The prognostic value of molecular biological and other factors is object of research, only a combination of some of these factors could be demonstrated so far to be superior to the estimation of the proportion of high grade cancer. However, at present their routine use in daily practise is precluded by a high technical and financial expense.",
author = "M Graefen and P Hammerer and J Noldus and Alexander Haese and U Pichelmeier and A Erbersdobler and H Henke and S Conrad and S Fernandez and H Huland",
year = "2000",
language = "Deutsch",
volume = "39",
pages = "14--21",
journal = "UROLOGE",
issn = "0340-2592",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - [Prognostic markers for prostate cancer]

AU - Graefen, M

AU - Hammerer, P

AU - Noldus, J

AU - Haese, Alexander

AU - Pichelmeier, U

AU - Erbersdobler, A

AU - Henke, H

AU - Conrad, S

AU - Fernandez, S

AU - Huland, H

PY - 2000

Y1 - 2000

N2 - Careful consideration of therapy for prostate cancer needs an accurate analysis of prognostic markers to estimate success and benefit for the patient. Prognosis of prostate cancer is determined by the proportion of high grade cancer, many usually utilized prognostic characteristics were rejected by multivariate analysis as no independent prognostic information was delivered. For planning therapy it is crucial to estimate the proportion of high grade cancer as exact as possible. A standardized biopsy technique combined with a quantified analysis of the biopsy cores is most helpful to achieve this goal. The prognostic value of molecular biological and other factors is object of research, only a combination of some of these factors could be demonstrated so far to be superior to the estimation of the proportion of high grade cancer. However, at present their routine use in daily practise is precluded by a high technical and financial expense.

AB - Careful consideration of therapy for prostate cancer needs an accurate analysis of prognostic markers to estimate success and benefit for the patient. Prognosis of prostate cancer is determined by the proportion of high grade cancer, many usually utilized prognostic characteristics were rejected by multivariate analysis as no independent prognostic information was delivered. For planning therapy it is crucial to estimate the proportion of high grade cancer as exact as possible. A standardized biopsy technique combined with a quantified analysis of the biopsy cores is most helpful to achieve this goal. The prognostic value of molecular biological and other factors is object of research, only a combination of some of these factors could be demonstrated so far to be superior to the estimation of the proportion of high grade cancer. However, at present their routine use in daily practise is precluded by a high technical and financial expense.

M3 - SCORING: Zeitschriftenaufsatz

VL - 39

SP - 14

EP - 21

JO - UROLOGE

JF - UROLOGE

SN - 0340-2592

IS - 1

M1 - 1

ER -